Publications by authors named "Rohit Swami"

Claim this Profile
C
Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study.
Vikas Ostwal, Anant Ramaswamy, Prabhat Bhargava, Tejaswee Hatkhambkar, Rohit Swami

BMJ Open· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-pathological correlates and survival outcomes in 214 resected ampullary adenocarcinomas - are outcomes different in intestinal and pancreatobiliary subtypes with adjuvant gemcitabine?
Anant Ramaswamy, Manish Bhandare, Munita Bal, Sameer Shrirangwar, Pritam Kataria, Rohit Swami

HPB (Oxford)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Vijay Maruti Patil, Vanita Noronha, Amit Joshi, Jaiprakash Agarwal, Sarbani Ghosh-Laskar, Rohit Swami

Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward.
Vikas Ostwal, Rohit Swami, Shraddha Patkar, Swaratika Majumdar, Mahesh Goel

Med Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early outcomes of exon 11 mutants in GIST treated with standard dose Imatinib.
Anant Ramaswamy, Munita Bal, Rohit Swami, Omshree Shetty, Subhadeep Bose

Ann Transl Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis